ANDRINI, ELISA
ANDRINI, ELISA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Assegnisti
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC
2024 Andrini E.; Ricco G.; Zappi A.; Aloi S.; Giordano M.; Altimari A.; Gruppioni E.; Maloberti T.; de Biase D.; Campana D.; Lamberti G.
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients
2024 Bonazzi, Norma; Fortunati, Emilia; Zanoni, Lucia; Argalia, Giulia; Calabrò, Diletta; Tabacchi, Elena; Allegri, Vincenzo; Campana, Davide; Andrini, Elisa; Lamberti, Giuseppe; Di Franco, Martina; Casadei, Riccardo; Ricci, Claudio; Mosconi, Cristina; Fanti, Stefano; Ambrosini, Valentina
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort
2024 Panzuto F.; Andrini E.; Lamberti G.; Pusceddu S.; Rinzivillo M.; Gelsomino F.; Raimondi A.; Bongiovanni A.; Davi M.V.; Cives M.; Brizzi M.P.; Persano I.; Zatelli M.C.; Puliafito I.; Tafuto S.; Campana D.
β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients
2024 Di Franco M.; Fortunati E.; Zanoni L.; Bonazzi N.; Mosconi C.; Malizia C.; Civollani S.; Campana D.; Andrini E.; Lamberti G.; Allegri V.; Fanti S.; Ambrosini V.
An Update on Appendiceal Neuroendocrine Tumors
2023 Andrini E.; Lamberti G.; Alberici L.; Ricci C.; Campana D.
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature
2023 Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; Lamberti G.
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review
2023 Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Maria Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm
2023 Lamberti, Giuseppe; Andrini, Elisa; Ricci, Claudio; Campana, Davide
Peripheral nervous system adverse events associated with immune checkpoint inhibitors
2023 Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lamberti G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M.
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
2023 Nicole Brighi; Giuseppe Lamberti; Elisa Andrini; Cristina Mosconi; Lisa Manuzzi; Giada Donati; Andrea Lisotti; Davide Campana
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
2023 Lamberti G.; Prinzi N.; Bongiovanni A.; Torniai M.; Andrini E.; Biase D.D.; Malvi D.; Mosca M.; Berardi R.; Ibrahim T.; Pusceddu S.; Campana D.
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
2022 Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
2022 Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.; Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G.
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities
2022 De Giglio, A.; Orlando, V.; Andrini, E.; Ricciuti, B.; Lamberti, G.; Chiari, R.
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer
2022 Ricciuti B.; Mira A.; Andrini E.; Scaparone P.; Michelina S.V.; Pecci F.; Cantini L.; De Giglio A.; Lamberti G.; Ambrogio C.; Metro G.
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies
2022 Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelsomino F.
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges
2022 Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D.; Lamberti G.
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis
2022 Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; Casadei R.; Campana D.
Non-small-cell lung cancer: how to manage RET-positive disease
2022 Andrini E.; Mosca M.; Galvani L.; Sperandi F.; Ricciuti B.; Metro G.; Lamberti G.
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
2022 Cortellini A.; Ricciuti B.; Vaz V.R.; Soldato D.; Alessi J.V.; Dall'olio F.G.; Banna G.L.; Muthuramalingam S.; Chan S.; Majem M.; Piedra A.; Lamberti G.; Andrini E.; Addeo A.; Friedlaender A.; Facchinetti F.; Gorria T.; Mezquita L.; Hoton D.; Valerie L.; Nana F.A.; Artingstall J.; Comins C.; Di Maio M.; Caglio A.; Cave J.; McKenzie H.; Newsom-Davis T.; Evans J.S.; Tiseo M.; D'Alessio A.; Fulgenzi C.A.M.; Besse B.; Awad M.M.; Pinato D.J.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Challenges and future perspectives for the use of temozolomide in the treatment of SCLC | Andrini E.; Ricco G.; Zappi A.; Aloi S.; Giordano M.; Altimari A.; Gruppioni E.; Maloberti T.; de... Biase D.; Campana D.; Lamberti G. | 2024-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | - |
| Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients | Bonazzi, Norma; Fortunati, Emilia; Zanoni, Lucia; Argalia, Giulia; Calabrò, Diletta; Tabacchi, El...ena; Allegri, Vincenzo; Campana, Davide; Andrini, Elisa; Lamberti, Giuseppe; Di Franco, Martina; Casadei, Riccardo; Ricci, Claudio; Mosconi, Cristina; Fanti, Stefano; Ambrosini, Valentina | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-00701.pdf |
| Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort | Panzuto F.; Andrini E.; Lamberti G.; Pusceddu S.; Rinzivillo M.; Gelsomino F.; Raimondi A.; Bongi...ovanni A.; Davi M.V.; Cives M.; Brizzi M.P.; Persano I.; Zatelli M.C.; Puliafito I.; Tafuto S.; Campana D. | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-13-02074.pdf |
| β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients | Di Franco M.; Fortunati E.; Zanoni L.; Bonazzi N.; Mosconi C.; Malizia C.; Civollani S.; Campana ...D.; Andrini E.; Lamberti G.; Allegri V.; Fanti S.; Ambrosini V. | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-13-03841-v2.pdf |
| An Update on Appendiceal Neuroendocrine Tumors | Andrini E.; Lamberti G.; Alberici L.; Ricci C.; Campana D. | 2023-01-01 | CURRENT TREATMENT OPTIONS IN ONCOLOGY | - | 1.01 Articolo in rivista | Andrini_2023.pdf |
| BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature | Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; ...Lamberti G. | 2023-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review | Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Mar...ia Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA | 2023-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-12-00717.pdf |
| Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm | Lamberti, Giuseppe; Andrini, Elisa; Ricci, Claudio; Campana, Davide | 2023-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Peripheral nervous system adverse events associated with immune checkpoint inhibitors | Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lambert...i G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M. | 2023-01-01 | JOURNAL OF NEUROLOGY | - | 1.01 Articolo in rivista | Rossi_JN_2023.pdf |
| Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors | Nicole Brighi; Giuseppe Lamberti; Elisa Andrini; Cristina Mosconi; Lisa Manuzzi; Giada Donati; An...drea Lisotti; Davide Campana | 2023-01-01 | CURRENT ONCOLOGY | - | 1.01 Articolo in rivista | curroncol-30-00106-v2.pdf |
| Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) | Lamberti G.; Prinzi N.; Bongiovanni A.; Torniai M.; Andrini E.; Biase D.D.; Malvi D.; Mosca M.; B...erardi R.; Ibrahim T.; Pusceddu S.; Campana D. | 2023-01-01 | DIAGNOSTICS | - | 1.01 Articolo in rivista | diagnostics-13-01595-v3.pdf; diagnostics-13-01595-s001.zip |
| A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale | Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea | 2022-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease | Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.;... Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G. | 2022-01-01 | DRUGS IN CONTEXT | - | 1.01 Articolo in rivista | - |
| Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities | De Giglio, A.; Orlando, V.; Andrini, E.; Ricciuti, B.; Lamberti, G.; Chiari, R. | 2022-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |
| How to manage KRAS G12C-mutated advanced non-small-cell lung cancer | Ricciuti B.; Mira A.; Andrini E.; Scaparone P.; Michelina S.V.; Pecci F.; Cantini L.; De Giglio A....; Lamberti G.; Ambrogio C.; Metro G. | 2022-01-01 | DRUGS IN CONTEXT | - | 1.01 Articolo in rivista | - |
| Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies | Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelso...mino F. | 2022-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges | Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D....; Lamberti G. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-11-01461.pdf |
| Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis | Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; C...asadei R.; Campana D. | 2022-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Lamberti_Cancer Medicine_2022.pdf; Downloads.zip |
| Non-small-cell lung cancer: how to manage RET-positive disease | Andrini E.; Mosca M.; Galvani L.; Sperandi F.; Ricciuti B.; Metro G.; Lamberti G. | 2022-01-01 | DRUGS IN CONTEXT | - | 1.01 Articolo in rivista | - |
| Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations | Cortellini A.; Ricciuti B.; Vaz V.R.; Soldato D.; Alessi J.V.; Dall'olio F.G.; Banna G.L.; Muthur...amalingam S.; Chan S.; Majem M.; Piedra A.; Lamberti G.; Andrini E.; Addeo A.; Friedlaender A.; Facchinetti F.; Gorria T.; Mezquita L.; Hoton D.; Valerie L.; Nana F.A.; Artingstall J.; Comins C.; Di Maio M.; Caglio A.; Cave J.; McKenzie H.; Newsom-Davis T.; Evans J.S.; Tiseo M.; D'Alessio A.; Fulgenzi C.A.M.; Besse B.; Awad M.M.; Pinato D.J. | 2022-01-01 | JOURNAL FOR IMMUNOTHERAPY OF CANCER | - | 1.01 Articolo in rivista | Cortellini et al, Journal for ImmunoTherapy of Cancer 2022.pdf; jitc-2021-004374supp001_data_supplement.pdf |